|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/26 | |
| A61P 3/08 | |||
| C07K 14/605 |
| (11) | Patento numeris | 2694095 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12768072.6 |
| Europos patento paraiškos padavimo data | 2012-04-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-02-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-03-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/032441 |
| Data | 2012-04-05 |
| (87) | Numeris | WO 2012/138941 |
| Data | 2012-10-11 |
| (30) | Numeris | Data | Šalis |
| 201161472149 P | 2011-04-05 | US | |
| 201161540526 P | 2011-09-28 | US |
| (72) |
SHANDLER, Scott, US
GELLMAN, Samuel H, US
|
| (73) |
Longevity Biotech, Inc.,
3624 Market Street Suite 300, Philadelphia, PA 19104,
US
|
| (54) | COMPOSITIONS COMPRISING GLUCAGON ANALOGS AND METHODS OF MAKING AND USING THE SAME |
| COMPOSITIONS COMPRISING GLUCAGON ANALOGS AND METHODS OF MAKING AND USING THE SAME |